Srivastava, Sanjeev Kumar
Khan, Mohammad Aslam
Anand, Shashi
Zubair, Haseeb
Deshmukh, Sachin Kumar
Patel, Girijesh Kumar
Singh, Seema
Andrews, Joel
Wang, Bin
Carter, James Elliot
Singh, Ajay Pratap https://orcid.org/0000-0003-3492-6330
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA204801, R01CA231925, U01CA185490, R01CA224306)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 9 July 2021
Revised: 27 October 2021
Accepted: 10 November 2021
First Online: 26 November 2021
Competing interests
: The authors declare no competing interests.
: The study involved no human subjects. Only the de-identified and archived human prostate cancer tissues were used under an exempt (category 4) protocol as determined by the University of South Alabama Institutional Review Board.
: Not applicable.